Skip to main content
Top
Published in: BMC Medical Genetics 1/2019

Open Access 01-12-2019 | Cystic Fibrosis | Case report

Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka

Authors: Neluwa Liyanage Ruwan Indika, Dinesha Maduri Vidanapathirana, Hewa Warawitage Dilanthi, Grace Angeline Malarnangai Kularatnam, Nambage Dona Priyani Dhammika Chandrasiri, Eresha Jasinge

Published in: BMC Medical Genetics | Issue 1/2019

Login to get access

Abstract

Background

Cystic fibrosis has been largely under-diagnosed and thus, limited data is available on the incidence of cystic fibrosis in Sri Lanka. Our aim is to describe the phenotypic and genotypic spectrum of children with cystic fibrosis in Sri Lanka.

Case presentation

This report describes 10 unrelated cystic fibrosis cases with phenotypic features of cystic fibrosis and abnormal or intermediate sweat tests. The most common phenotypic features in this sample of symptomatic patients were persistent or recurrent lower respiratory tract infections, failure to thrive and Pseudo-Bartter syndrome. Altogether 7 cystic fibrosis causing mutations were identified in 10 patients. Except delta F508 which is the commonest mutation worldwide all the other mutations detected in Sri Lankan patients are rare mutations. 1161delC and V456A detected in our patients are South Asian mutations. The other mutations such as [C.1282C > G; C.2738A > G], C.53 + 1G > C, 2184insA and a deletion encompassing exons 4 to 11 have been reported previously from European patients with cystic fibrosis.

Conclusion

These cases highlight the importance of considering the diagnosis of cystic fibrosis in children and young adults presenting with persistent respiratory tract infections associated with severe malnutrition and Pseudo-Bartter syndrome, especially in low income countries where newborn screening for cystic fibrosis is not available. The spectrum of CFTR mutations in Sri Lanka is heterogeneous and possibly linked to genetic flow from Indian subcontinent and Europe. The common mutations should be identified by sequencing the entire CFTR gene in adequate number of cystic fibrosis patients in order to design a mutation panel for common regional mutations.
Literature
1.
go back to reference Welsh MJ, Ramsay BW, Accurso F, Cutting GR. Cystic Fibrosis. In: WS SABCS, Valle D, editors. Molecular and Metabolic Basis of Inherited Disease. 8th ed: McGrow-Hill; Newyork, 2001. p. 5121–88. Welsh MJ, Ramsay BW, Accurso F, Cutting GR. Cystic Fibrosis. In: WS SABCS, Valle D, editors. Molecular and Metabolic Basis of Inherited Disease. 8th ed: McGrow-Hill; Newyork, 2001. p. 5121–88.
2.
go back to reference Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, et al. Diagnosis of cystic fibrosis in screened populations. J Pediatr. 2017;181:S33–44.CrossRef Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, et al. Diagnosis of cystic fibrosis in screened populations. J Pediatr. 2017;181:S33–44.CrossRef
3.
go back to reference Sosnay PR, White TB, Farrell PM, Ren CL, Derichs N, Howenstine MS, et al. Diagnosis of cystic fibrosis in nonscreened populations. J Pediatr. 2017;181:S52–7.CrossRef Sosnay PR, White TB, Farrell PM, Ren CL, Derichs N, Howenstine MS, et al. Diagnosis of cystic fibrosis in nonscreened populations. J Pediatr. 2017;181:S52–7.CrossRef
4.
go back to reference De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge J, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax. 2006;61(7):627–35.CrossRef De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge J, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax. 2006;61(7):627–35.CrossRef
5.
go back to reference Mishra A, Greaves R, Massie J. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev. 2005;26(4):135–53.PubMedPubMedCentral Mishra A, Greaves R, Massie J. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev. 2005;26(4):135–53.PubMedPubMedCentral
6.
go back to reference Sosnay PR, Salinas DB, White TB, Ren CL, Farrell PM, Raraigh KS, et al. Applying cystic fibrosis transmembrane conductance regulator genetics and CFTR2 data to facilitate diagnoses. J Pediatr. 2017;181:S27–32 e1.CrossRef Sosnay PR, Salinas DB, White TB, Ren CL, Farrell PM, Raraigh KS, et al. Applying cystic fibrosis transmembrane conductance regulator genetics and CFTR2 data to facilitate diagnoses. J Pediatr. 2017;181:S27–32 e1.CrossRef
7.
go back to reference Harendra de Silva DG, Lakkumar Fernando AJA, Senaka Gunatilleke MDA. Cystic fibrosis in Sri Lanka. The Ceylon Med J. 1994;39(1):50–2.PubMed Harendra de Silva DG, Lakkumar Fernando AJA, Senaka Gunatilleke MDA. Cystic fibrosis in Sri Lanka. The Ceylon Med J. 1994;39(1):50–2.PubMed
8.
go back to reference Sweat CLSI. Testing: Sample Collection and Quantitative Chloride Analysis; Approved Guideline - Third Edition. CLSI document C34 - A3, PA. Clinical and Laboratory Standards Institute; 2009. Sweat CLSI. Testing: Sample Collection and Quantitative Chloride Analysis; Approved Guideline - Third Edition. CLSI document C34 - A3, PA. Clinical and Laboratory Standards Institute; 2009.
9.
go back to reference Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017;181:S4–S15 e1.CrossRef Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017;181:S4–S15 e1.CrossRef
11.
go back to reference Ranaweera L, Kaewsutthi S, Tun AW, Boonyarit H, Poolsuwan S, Lertrit P. Mitochondrial DNA history of Sri Lankan ethnic people: their relations within the island and with the Indian subcontinental populations. J H Genet. 2013;59(1):28.CrossRef Ranaweera L, Kaewsutthi S, Tun AW, Boonyarit H, Poolsuwan S, Lertrit P. Mitochondrial DNA history of Sri Lankan ethnic people: their relations within the island and with the Indian subcontinental populations. J H Genet. 2013;59(1):28.CrossRef
12.
go back to reference Malavige GN, Rostron T, Seneviratne SL, Fernando S, Sivayogan S, Wijewickrama A, et al. HLA analysis of Sri Lankan Sinhalese predicts North Indian origin. Int J Immunogenet. 2007;34(5):313–5.CrossRef Malavige GN, Rostron T, Seneviratne SL, Fernando S, Sivayogan S, Wijewickrama A, et al. HLA analysis of Sri Lankan Sinhalese predicts North Indian origin. Int J Immunogenet. 2007;34(5):313–5.CrossRef
13.
go back to reference Soejima M, Koda Y. Denaturing high-performance liquid chromatography-based genotyping and genetic variation of FUT2 in Sri Lanka. Transfusion. 2005;45(12):1934–9.CrossRef Soejima M, Koda Y. Denaturing high-performance liquid chromatography-based genotyping and genetic variation of FUT2 in Sri Lanka. Transfusion. 2005;45(12):1934–9.CrossRef
14.
go back to reference Roychoudhury AK, Nei M. Genetic relationships between Indians and their neighboring populations. Hum Hered. 1985;35(4):201–6.CrossRef Roychoudhury AK, Nei M. Genetic relationships between Indians and their neighboring populations. Hum Hered. 1985;35(4):201–6.CrossRef
15.
go back to reference Sharma N, Singh M, Kaur G, Thapa BR, Prasad R. Identification and characterization of CFTR gene mutations in Indian CF patients. Ann Hum Genet. 2009;73(1):26–33.CrossRef Sharma N, Singh M, Kaur G, Thapa BR, Prasad R. Identification and characterization of CFTR gene mutations in Indian CF patients. Ann Hum Genet. 2009;73(1):26–33.CrossRef
16.
go back to reference Shastri SS, Kabra M, Kabra SK, Pandey RM, Menon PSN. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India. J Cyst Fibros. 2008;7(2):110–5.CrossRef Shastri SS, Kabra M, Kabra SK, Pandey RM, Menon PSN. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India. J Cyst Fibros. 2008;7(2):110–5.CrossRef
18.
go back to reference Giglio L, Candusso M, D'Orazio C, Mastella G, Faraguna D. Failure to thrive: the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening. Acta Paediatr. 1997;86(11):1162–5.CrossRef Giglio L, Candusso M, D'Orazio C, Mastella G, Faraguna D. Failure to thrive: the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening. Acta Paediatr. 1997;86(11):1162–5.CrossRef
19.
go back to reference Scurati-Manzoni E, Fossali EF, Agostoni C, Riva E, Simonetti GD, Zanolari-Calderari M, et al. Electrolyte abnormalities in cystic fibrosis: systematic review of the literature. Pediatr Nephrol. 2014;29(6):1015–23.CrossRef Scurati-Manzoni E, Fossali EF, Agostoni C, Riva E, Simonetti GD, Zanolari-Calderari M, et al. Electrolyte abnormalities in cystic fibrosis: systematic review of the literature. Pediatr Nephrol. 2014;29(6):1015–23.CrossRef
20.
go back to reference Rodman DM, Polis JM, Heltshe SL, Sontag MK, Chacon C, Rodman RV, et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med. 2005;171(6):621–6.CrossRef Rodman DM, Polis JM, Heltshe SL, Sontag MK, Chacon C, Rodman RV, et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med. 2005;171(6):621–6.CrossRef
21.
go back to reference Ashavaid TF, Raghavan R, Dhairyawan P, Bhawalkar S. Cystic fibrosis in India: a systematic review. J Assoc Physicians India. 2012;60:39–41.PubMed Ashavaid TF, Raghavan R, Dhairyawan P, Bhawalkar S. Cystic fibrosis in India: a systematic review. J Assoc Physicians India. 2012;60:39–41.PubMed
22.
go back to reference Kularatnam GAM, Warawita D, Jayasena S, Nadarajah S, Jasinge E, Mendis D, et al. Cystic fibrosis in a Sri Lankan infant, confirmed by genotyping: implications for future diagnosis and service provision. J Postgraduate Inst Med. 2015;2:E17:1–3.CrossRef Kularatnam GAM, Warawita D, Jayasena S, Nadarajah S, Jasinge E, Mendis D, et al. Cystic fibrosis in a Sri Lankan infant, confirmed by genotyping: implications for future diagnosis and service provision. J Postgraduate Inst Med. 2015;2:E17:1–3.CrossRef
23.
go back to reference Dilanthi HW, Vidanapathirana DM, Jayasena KLSPKM, Chandrasiri NDPD, Piumika UMT, Wickramarathne DKNP, et al. Pseudo-Bartter Syndrome in a Patient with Cystic Fibrosis: A Challenge in Diagnosis. College of Chemical Pathologists of Sri Lanka; Proceedings of 2nd Annual Academic Sessions 2017. [cited May 2019] Available from: http://www.ccpsrilanka.com/downloads.php. Dilanthi HW, Vidanapathirana DM, Jayasena KLSPKM, Chandrasiri NDPD, Piumika UMT, Wickramarathne DKNP, et al. Pseudo-Bartter Syndrome in a Patient with Cystic Fibrosis: A Challenge in Diagnosis. College of Chemical Pathologists of Sri Lanka; Proceedings of 2nd Annual Academic Sessions 2017. [cited May 2019] Available from: http://​www.​ccpsrilanka.​com/​downloads.​php.
24.
go back to reference Vidaud M, Fanen P, Martin J, Ghanem N, Nicolas S, Goossens M. Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis. Hum Genet. 1990;85(4):446–9.CrossRef Vidaud M, Fanen P, Martin J, Ghanem N, Nicolas S, Goossens M. Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis. Hum Genet. 1990;85(4):446–9.CrossRef
25.
go back to reference Gasparini P, Nunes V, Savoia A, Dognini M, Morral N, Gaona A, et al. The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences. Genomics. 1991;10(1):193–200.CrossRef Gasparini P, Nunes V, Savoia A, Dognini M, Morral N, Gaona A, et al. The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences. Genomics. 1991;10(1):193–200.CrossRef
26.
go back to reference Oller Ramirez AM, Ramos MD, Jimenez J, Ghio A, de Botelli MM, Rezzonico CA, et al. Mutational spectrum of cystic fibrosis patients from Cordoba province and its zone of influence: Implications of molecular diagnosis in Argentina. Mol Genet Metab. 2006;87(4):370–5.CrossRef Oller Ramirez AM, Ramos MD, Jimenez J, Ghio A, de Botelli MM, Rezzonico CA, et al. Mutational spectrum of cystic fibrosis patients from Cordoba province and its zone of influence: Implications of molecular diagnosis in Argentina. Mol Genet Metab. 2006;87(4):370–5.CrossRef
27.
go back to reference Makukh H, Křenková P, Tyrkus M, Bober L, Hančárová M, Hnateyko O, et al. A high frequency of the cystic fibrosis 2184insA mutation in Western Ukraine: genotype-phenotype correlations, relevance for newborn screening and genetic testing. J Cyst Fibros. 2010;9(5):371–5.CrossRef Makukh H, Křenková P, Tyrkus M, Bober L, Hančárová M, Hnateyko O, et al. A high frequency of the cystic fibrosis 2184insA mutation in Western Ukraine: genotype-phenotype correlations, relevance for newborn screening and genetic testing. J Cyst Fibros. 2010;9(5):371–5.CrossRef
28.
go back to reference Krenkova P, Piskackova T, Holubova A, Balaskakova M, Krulisova V, Camajova J, et al. Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations. J Cyst Fibros. 2013;12(5):532–7.CrossRef Krenkova P, Piskackova T, Holubova A, Balaskakova M, Krulisova V, Camajova J, et al. Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations. J Cyst Fibros. 2013;12(5):532–7.CrossRef
29.
go back to reference Ivady G, Koczok K, Madar L, Gombos E, Toth I, Gyori K, et al. Molecular Analysis of Cystic Fibrosis Patients in Hungary - An Update to the Mutational Spectrum. J Med Biochem. 2014;34(1):46–51.CrossRef Ivady G, Koczok K, Madar L, Gombos E, Toth I, Gyori K, et al. Molecular Analysis of Cystic Fibrosis Patients in Hungary - An Update to the Mutational Spectrum. J Med Biochem. 2014;34(1):46–51.CrossRef
30.
go back to reference Sobczynska-tomaszewska A, Oltarzewski M, Czerska K, Wertheim-tysarowska K, Sands D, Walkowiak J, et al. Newborn screening for cystic fibrosis: Polish 4 years’ experience with CFTR sequencing strategy. Eur J Hum Genet. 2013;21(4):391.CrossRef Sobczynska-tomaszewska A, Oltarzewski M, Czerska K, Wertheim-tysarowska K, Sands D, Walkowiak J, et al. Newborn screening for cystic fibrosis: Polish 4 years’ experience with CFTR sequencing strategy. Eur J Hum Genet. 2013;21(4):391.CrossRef
31.
go back to reference Dork T, Mekus F, Schmidt K, Bosshammer J, Fislage R, Heuer T, et al. Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients. Hum Genet. 1994;94(5):533–42.CrossRef Dork T, Mekus F, Schmidt K, Bosshammer J, Fislage R, Heuer T, et al. Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients. Hum Genet. 1994;94(5):533–42.CrossRef
32.
go back to reference Kolesar P, Minarik G, Baldovic M, Ficek A, Kovacs L, Kadasi L. Mutation analysis of the CFTR gene in Slovak cystic fibrosis patients by DHPLC and subsequent sequencing: identification of four novel mutations. Gen Physiol Biophys. 2008;27(4):299.PubMed Kolesar P, Minarik G, Baldovic M, Ficek A, Kovacs L, Kadasi L. Mutation analysis of the CFTR gene in Slovak cystic fibrosis patients by DHPLC and subsequent sequencing: identification of four novel mutations. Gen Physiol Biophys. 2008;27(4):299.PubMed
33.
go back to reference Angelicheva D, Calafell F, Savov A, Jordanova A, Kufardjieva A, Galeva I, et al. Cystic fibrosis mutations and associated haplotypes in Bulgaria - a comparative population genetic study. Hum Genet. 1997;99(4):513–20.CrossRef Angelicheva D, Calafell F, Savov A, Jordanova A, Kufardjieva A, Galeva I, et al. Cystic fibrosis mutations and associated haplotypes in Bulgaria - a comparative population genetic study. Hum Genet. 1997;99(4):513–20.CrossRef
34.
go back to reference Bonyadi M, Omrani O, Rafeey M, Bilan N. Spectrum of CFTR gene mutations in Iranian Azeri Turkish patients with cystic fibrosis. Genet Test Mol Biomarkers. 2011;15(1-2):89–92.CrossRef Bonyadi M, Omrani O, Rafeey M, Bilan N. Spectrum of CFTR gene mutations in Iranian Azeri Turkish patients with cystic fibrosis. Genet Test Mol Biomarkers. 2011;15(1-2):89–92.CrossRef
35.
go back to reference Neocleous V, Yiallouros PK, Tanteles GA, Costi C, Moutafi M, Ioannou P, et al. Apparent Homozygosity of p. Phe508del in CFTR due to a Large Gene Deletion of Exons 4-11. Case Rep Genet. 2014;2014:4. Neocleous V, Yiallouros PK, Tanteles GA, Costi C, Moutafi M, Ioannou P, et al. Apparent Homozygosity of p. Phe508del in CFTR due to a Large Gene Deletion of Exons 4-11. Case Rep Genet. 2014;2014:4.
36.
go back to reference Uppaluri L, England SJ, Scanlin TF. Clinical evidence that V456A is a Cystic Fibrosis causing mutation in South Asians. J Cyst Fibros. 2012;11(4):312–5.CrossRef Uppaluri L, England SJ, Scanlin TF. Clinical evidence that V456A is a Cystic Fibrosis causing mutation in South Asians. J Cyst Fibros. 2012;11(4):312–5.CrossRef
37.
go back to reference Mandal A, Kabra SK, Lodha R. Cystic fibrosis in India: past, present and future. J Pulm Med Respir Res. 2015;1(002). Mandal A, Kabra SK, Lodha R. Cystic fibrosis in India: past, present and future. J Pulm Med Respir Res. 2015;1(002).
38.
go back to reference Malone G, Haworth A, Schwarz MJ, Cuppens H, Super M. Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani patients with cystic fibrosis: Y569D, Q98X, 296+ 12 (T> C), 1161delC and 621+ 2 (T> C). Hum Mutat. 1998;11(2):152–7.CrossRef Malone G, Haworth A, Schwarz MJ, Cuppens H, Super M. Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani patients with cystic fibrosis: Y569D, Q98X, 296+ 12 (T> C), 1161delC and 621+ 2 (T> C). Hum Mutat. 1998;11(2):152–7.CrossRef
40.
go back to reference Mei-Zahav M, Solomon M, Kawamura A, Coates A, Durie P. Cystic fibrosis presenting as kwashiorkor in a Sri Lankan infant. Arch Dis Child. 2003;88(8):724–5.CrossRef Mei-Zahav M, Solomon M, Kawamura A, Coates A, Durie P. Cystic fibrosis presenting as kwashiorkor in a Sri Lankan infant. Arch Dis Child. 2003;88(8):724–5.CrossRef
41.
go back to reference Mei-Zahav M, Durie P, Zielenski J, Solomon M, Tullis E, Tsui LC, et al. The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants. Arch Dis Child. 2005;90(7):675–9.CrossRef Mei-Zahav M, Durie P, Zielenski J, Solomon M, Tullis E, Tsui LC, et al. The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants. Arch Dis Child. 2005;90(7):675–9.CrossRef
42.
go back to reference Wahab A, Al Thani G, Dawod ST, Kambouris M, Al Hamed M. Rare CFTR mutation 1525-1G> A in a Pakistani patient. J Trop Pediatr. 2004;50(2):120–2.CrossRef Wahab A, Al Thani G, Dawod ST, Kambouris M, Al Hamed M. Rare CFTR mutation 1525-1G> A in a Pakistani patient. J Trop Pediatr. 2004;50(2):120–2.CrossRef
43.
go back to reference Ramalho AS, Beck S, Penque D, Gonska T, Seydewitz HH, Mall M, et al. Transcript analysis of the cystic fibrosis splicing mutation 1525-1G> A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers. J Med Genet. 2003;40(7):e88.CrossRef Ramalho AS, Beck S, Penque D, Gonska T, Seydewitz HH, Mall M, et al. Transcript analysis of the cystic fibrosis splicing mutation 1525-1G> A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers. J Med Genet. 2003;40(7):e88.CrossRef
44.
go back to reference Nikolic A, Radlovic N, Dinic J, Milosevic K, Radojkovic D. Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c. 1393-1G> A. J Cyst Fibros. 2014;13(1):111–3.CrossRef Nikolic A, Radlovic N, Dinic J, Milosevic K, Radojkovic D. Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c. 1393-1G> A. J Cyst Fibros. 2014;13(1):111–3.CrossRef
45.
go back to reference WHO Human Genetics Programme. The Molecular Genetic Epidemiology of Cystic Fibrosis: Report of a Joint Meeting of WHO/ECFTN/ICF(M)A/ECFS, Genoa, Italy, 19 June 2002: World Health Organization; 2004. WHO Human Genetics Programme. The Molecular Genetic Epidemiology of Cystic Fibrosis: Report of a Joint Meeting of WHO/ECFTN/ICF(M)A/ECFS, Genoa, Italy, 19 June 2002: World Health Organization; 2004.
46.
go back to reference Implementation of cystic fibrosis services in developing countries: memorandum from a Joint WHO/ICF(M)A meeting. Bull World Health Organ. 1997;75(1):1–10. Implementation of cystic fibrosis services in developing countries: memorandum from a Joint WHO/ICF(M)A meeting. Bull World Health Organ. 1997;75(1):1–10.
47.
go back to reference McCormick J, Ogston SA, Sims EJ, Mehta A. Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous delta F508 controls. J Cyst Fibros. 2005;4(1):53–8.CrossRef McCormick J, Ogston SA, Sims EJ, Mehta A. Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous delta F508 controls. J Cyst Fibros. 2005;4(1):53–8.CrossRef
48.
go back to reference Kabra SK, Kabra M, Shastri S, Lodha R. Diagnosing and managing cystic fibrosis in the developing world. Paediatr Respir Rev. 2006;7:S147–50.CrossRef Kabra SK, Kabra M, Shastri S, Lodha R. Diagnosing and managing cystic fibrosis in the developing world. Paediatr Respir Rev. 2006;7:S147–50.CrossRef
Metadata
Title
Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka
Authors
Neluwa Liyanage Ruwan Indika
Dinesha Maduri Vidanapathirana
Hewa Warawitage Dilanthi
Grace Angeline Malarnangai Kularatnam
Nambage Dona Priyani Dhammika Chandrasiri
Eresha Jasinge
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2019
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/s12881-019-0815-x

Other articles of this Issue 1/2019

BMC Medical Genetics 1/2019 Go to the issue